Conceivable Produces Fertility App With Seed Funding

An Austin, TX-based company is introducing an app today that incorporates Chinese medicine practices that are meant to help women get pregnant.

The company, called Conceivable, has raised $800,000 in seed funding to make the app available for consumer use. A user of the app answers questions about, among other things, any abnormalities in her menstrual cycle, her body temperature, and her eating habits. Conceivable then builds a program for the user to follow that its founders believe will help her get pregnant and make the pregnancy run more smoothly.

“We wanted to develop a program that could actually identify where the breakdowns in the progress are for each user, and use behavioral science to identify very small steps to make permanent lifestyle changes,” said co-founder and CEO Kirsten Karchmer.

Karchmer and co-founder Rob Krassowski built the company after spending years at The Texas Center for Reproductive Acupuncture, where practitioners use Chinese medicine-based acupuncture techniques on infertility. While working with patients at the center and elsewhere, Karchmer developed the algorithm for the Conceivable app based on information she would gather to make assessments on how to treat them.

Conceivable, which charges $199 per month for the treatment plan, expects most folks to spend about six months on the program; it would need about 2,000 users to sign up to be profitable, Karchmer said. The plans are intended to encourage positive health habits, from diet to stress reduction. It updates on a weekly basis.

About a third of the seed funding came from Karchmer’s former patients, with the rest being raised from Austin angel investors and former venture capitalists, she said. The company is considering other indications for the app, including one focused on men.

Author: David Holley

David is the national correspondent at Xconomy. He has spent most of his career covering business of every kind, from breweries in Oregon to investment banks in New York. A native of the Pacific Northwest, David started his career reporting at weekly and daily newspapers, covering murder trials, city council meetings, the expanding startup tech industry in the region, and everything between. He left the West Coast to pursue business journalism in New York, first writing about biotech and then private equity at The Deal. After a stint at Bloomberg News writing about high-yield bonds and leveraged loans, David relocated from New York to Austin, TX. He graduated from Portland State University.